XCMR’s team presented groundbreaking research at the inaugural ICFUST conference, which convened more than 200 attendees to discuss advancements in Far UV-C technology. The event focused on the latest applications of Far UV-C for public health, pathogen inactivation, and environmental protection.
Eric Prast presented XCMR’s innovations in Far UV-C technology, which integrate 222 nm light into wearable PPE to inactivate airborne pathogens. The miniature, battery-powered device disinfects air in real time, creating a safe breathing environment while reducing biohazard waste. The device demonstrated an impressive 97.5% inactivation rate of T1 phage, with the potential to combat pathogens like SARS-CoV-2.
Dr. Bowers showcased the use of ray-tracing and computational fluid dynamics (CFD) to enhance the design of Far UV-C-based PPE. The simulations highlighted how reflective materials can significantly increase UV-C exposure, optimizing pathogen inactivation. This research is crucial for the rapid development of advanced PPE for public health protection.
Dr. Li and Dr. Ernest R. Blatchley III introduced a novel method for quantifying the dose-response behavior of aerosolized viruses when exposed to UV222 radiation. Using a continuous-flow, square quartz channel reactor, they demonstrated the inactivation of airborne viruses, providing valuable data for developing Far UV-C-based disinfection systems for indoor air as well as for near-field protection devices.
XCMR’s participation at the First International Congress on Far-UVC Science and Technology demonstrated its leadership in applying Far UV-C light to improve public health. The research presented by XCMR’s diverse team members emphasized the potential of Far UV-C to enhance pathogen inactivation, offering sustainable and effective solutions for combating airborne diseases. As the capabilities of Far UV-C technology continue to evolve, XCMR remains at the forefront of driving innovation and global health safety.
